.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Escitalopram oxalate - Generic Drug Details

« Back to Dashboard
Escitalopram oxalate is the generic ingredient in two branded drugs marketed by Invagen Pharms, Macleods Pharms Ltd, Sti Pharma Llc, Hetero Labs Ltd Iii, Taro, Forest Labs, Amneal Pharms, Aurobindo Pharma Ltd, Prinston Inc, Zydus Pharms Usa Inc, Torrent Pharms Ltd, Mylan Pharms Inc, Teva Pharms Usa, Hikma Pharms, Antrim Pharms Llc, Lupin Ltd, Silarx Pharms Inc, Apotex Inc, Jubilant Generics, and Accord Hlthcare, and is included in twenty-four NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for escitalopram oxalate. Fifty-nine suppliers are listed for this compound. There are six tentative approvals for this compound.

Summary for Generic Name: escitalopram oxalate

Tradenames:2
Patents:2
Applicants:20
NDAs:24
Drug Master File Entries: see list25
Suppliers / Packaging: see list59
Therapeutic Class:Antidepressants
Anxiolytics
Drug Prices:see low prices

Pharmacology for Ingredient: escitalopram oxalate

Tentative approvals for ESCITALOPRAM OXALATE

Applicant Application No. Form Dosage
<disabled><disabled>TABLET; ORAL5MG
<disabled><disabled>TABLET; ORAL10MG
<disabled><disabled>TABLET; ORAL20MG
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL078777-001Sep 11, 2012RXNo► subscribe► subscribe
Macleods Pharms Ltd
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL202210-003Sep 11, 2012RXNo► subscribe► subscribe
Prinston Inc
ESCITALOPRAM OXALATE
escitalopram oxalate
TABLET;ORAL078032-002Aug 28, 2015RXNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: escitalopram oxalate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Forest Labs
LEXAPRO
escitalopram oxalate
SOLUTION;ORAL021365-001Nov 27, 2002RE34712*PED► subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-002Aug 14, 2002RE34712*PED► subscribe
Forest Labs
LEXAPRO
escitalopram oxalate
TABLET;ORAL021323-003Aug 14, 2002RE34712*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc